2934738-38-0,Antileishmanial agent-15,2934738-41-5,Antileishmanial agent-16, CAS

TargetMol Chemicals Inc. 企業の連絡先情報

名前:	TargetMol Chemicals Inc.
電話番号:	-
電子メール:	marketing@targetmol.com
国籍:	China
ウェブサイト:	https://www.targetmol.cn/
商品の合計数:	19711

40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144

製品カタログ

STAT6-IN-3		371919-80-1	C32H35IN3O7P
SUCNR1-IN-1		2711753-52-3
Mcl-1 inhibitor 13		2445466-06-6
MEK-IN-6 hydrate		2845153-35-5
FKBP51F67V-selective antagonist Ligand2		1680228-76-5
DSO-5a		2195411-63-1
FD2056		2685870-87-3
Lp-PLA2-IN-15		1865796-11-7	C22H17F5N4O3
SLMP53-2		1826116-38-4	C26H22N2O2
SORT-PGRN interaction inhibitor 3		2691846-87-2	C15H19Cl2NO3
Antibacterial agent 141		2930013-56-0
Lp-PLA2-IN-14		2756855-66-8
SOS1/KRAS-IN-1		2836330-34-6
BDM91514		2892824-90-5
SARS-CoV-2-IN-57		1265624-68-7
HDAC ligand-1	2′-アミノホルムアニリド	34840-28-3	C7H8N2O
Bivamelagon hydrochloride		2641595-55-1	C35H54Cl2N4O4
VMAT2-IN-2 tosylate		2608770-12-1	C27H36F3NO6S
HIV-1 inhibitor-56		2952530-45-7
Antileishmanial agent-16		2934738-41-5
IRE1α kinase-IN-9		1338933-30-4
SHP2-IN-14		2673400-91-2
UPCDC30766		2152623-68-0
MmpL3-IN-2		2944458-65-3
TLR8 agonist 6		2616605-55-9	C19H29N7O2
Lp-PLA2-IN-16		1865780-73-9	C22H17F5N4O3
IPG7236		2756350-91-9	C23H31N3O3S
AMPA receptor modulator-4		2917551-59-6	C11H12ClFN2O2S
RIP1 kinase inhibitor 4		2919836-00-1
PCSK9-IN-17		2455424-72-1
BBDDL2059		2691174-27-1
JAK-IN-30		2891469-99-9
Antitubercular agent-39		1357796-08-7
Z1078601926		1493256-85-1	C14H19FN2O
PCSK9-IN-16		2455424-51-6	C16H20N6O2S3
DRI-C21041		2101765-78-8	C30H21N3O7S
KAT modulator-1		1314006-43-3	C20H36O2
Antiproliferative agent-32		2925814-05-5
Lp-PLA2-IN-12		2637485-14-2
RIP1 kinase inhibitor 7		2428401-23-2
K-80001		242800-40-4
AMPK activator 11		2948304-00-3
Anticancer agent 147		2241283-11-2
Bivamelagon		2641595-54-0	C35H53ClN4O4
ALK2-IN-5		2414149-20-3	C24H32N8O2
Tau protein aggregation-IN-1		916179-45-8	C17H11BrN2O2
Antileishmanial agent-17		2934738-40-4
THRβ receptor agonist-1		2403721-00-4
P2X3 antagonist 38		2545974-71-6
FGFR-IN-11		2658488-68-5
Antiproliferative agent-30		2713553-88-7
CDK7-IN-22		2173190-60-6	C22H25F3N6
PI3Kγ inhibitor 7		2575863-25-9
RIP1 kinase inhibitor 6		2428401-62-9
CXCR4-IN-1		2304750-48-7
PIKfyve-IN-2		2245319-25-7
PHD2-IN-1		2768219-28-7
ALK/EGFR-IN-1		2730430-08-5
RET-IN-23		2479961-46-9	C28H28FN11
TLR7/8 agonist 9		2649170-17-0	C20H26N6O
Mosnodenvir		2890688-86-3
URAT1&XO inhibitor 1		2669726-78-5
TNF-α-IN-10		2247720-56-3
MEK-IN-6		2845151-86-0
SOS1-IN-16		2930763-85-0
ETAP		2575731-47-2
Antiproliferative agent-34		2910858-34-1
S-Gem		2169925-98-6	C13H15F2N3O6S2
DRI-C25441		2101765-83-5	C31H21N3O6
Bromodomain inhibitor-12		2010124-06-6
PB131		2924425-63-6
Lp-PLA2-IN-13		2756855-62-4
JAK-IN-28		2445500-22-9
Tubulin polymerization-IN-42		2640220-51-3
BChE-IN-17		2425632-57-9
HPK1 antagonist-1		2628489-56-3	C28H29FN6O2
Antileishmanial agent-15		2934738-38-0
IRE1α kinase-IN-8		1338933-29-1
Antifungal agent 59		2422019-96-1
Antitumor agent-101		2848632-52-8
PAD4-IN-2		2642327-52-2
MAT2A-IN-12		631897-75-1	C20H17NO3
IRAK4-IN-28		2952532-92-0
Protein kinase inhibitor 5		2278204-94-5	C29H31F2N7O
DGKζ-IN-1		2660218-70-0	C27H25F3N6O2S
SSI-4		1875084-68-6	C19H21ClN4O3
ROCK-IN-6		2489328-74-5	C19H19N5O8S
MDM2/XIAP-IN-2		2761969-85-9	C29H32N2O4S
PROTAC α-synuclein degrader 5		2781922-42-5	C39H41N7O10
TLR7/8 agonist 8		2649170-16-9	C24H30N6O
URAT1&XO inhibitor 2		1239488-96-0	C14H12BrNO3
Tegeprotafib		2407610-46-0	C13H11FN2O5S
RIP1 kinase inhibitor 5		2428422-17-5	C13H17F2NO2
BET-IN-15		2408994-22-7	C21H18F2N4O3S
Bromodomain inhibitor-12 (edisylate)		2010124-27-1
Enpp-1-IN-17		2289736-54-3	C18H24N4O2
A1/A3 AR antagonist 3		2665804-57-7	C22H19N5O3
ATR-IN-24		2370889-43-1	C23H26N6O2
TRK-IN-23		2924344-29-4